Data gathered: April 15
AI Stock Analysis - Sana Biotechnology (SANA)
Analysis generated August 13, 2024. Powered by Chat GPT.
Sana Biotechnology is a biotechnology company specializing in creating and delivering engineered cells as a medication for patients. The company is at the cutting edge of the biotechnology industry, focusing on developing platforms intending to repair and control genes in cells and establish specific cell types to combat different diseases. The company’s ambitious goals are matched by its innovative approaches and significant investments in research and development.
Stock Alerts - Sana Biotechnology (SANA)
 |
Sana Biotechnology | April 11 Price is up by 10.1% in the last 24h. |
|
Sana Biotechnology | April 10 Price is down by -6.5% in the last 24h. |
|
Sana Biotechnology | April 9 Price is up by 7.1% in the last 24h. |
|
Sana Biotechnology | April 8 Price is up by 7.2% in the last 24h. |
Alternative Data for Sana Biotechnology
| Alternative Data | Value | 3m Change | Trend | Benchmark |
|---|---|---|---|---|
| Job Posts | 4 | Sign up | Sign up | Sign up |
| Sentiment | 75 | Sign up | Sign up | Sign up |
| Webpage traffic | 35,000 | Sign up | Sign up | Sign up |
| Employee Rating | 46 | Sign up | Sign up | Sign up |
| Google Trends | 3 | Sign up | Sign up | Sign up |
| 4chan Mentions | N/A | Sign up | Sign up | Sign up |
| Reddit Mentions | N/A | Sign up | Sign up | Sign up |
| Stocktwits Mentions | 10 | Sign up | Sign up | Sign up |
| Stocktwits Subscribers | 3,023 | Sign up | Sign up | Sign up |
| Twitter Mentions | 12 | Sign up | Sign up | Sign up |
| News Mentions | N/A | Sign up | Sign up | Sign up |
| Customer reviews | N/A | Sign up | Sign up | Sign up |
| Business Outlook | 10 | Sign up | Sign up | Sign up |
| Linkedin Employees | 267 | Sign up | Sign up | Sign up |
About Sana Biotechnology
Sana Biotechnology, Inc., a biotechnology company, focuses on utilizing engineered cells as medicines.
| Price | $1.81 |
| Target Price | Sign up |
| Volume | 2,940,000 |
| Market Cap | $396M |
| Year Range | $1.34 - $6.11 |
| Dividend Yield | 0% |
| Analyst Rating | 57% buy |
| Industry | Biotechnology |
In the news
Pomerantz Law Firm Announces the Filing of a Class Action Against Sana Biotechnology, Inc. and Certain Officers - SANAApril 13 - Finnhub |
|
SANA Investors Have Opportunity to Lead Sana Biotechnology, Inc. Securities Fraud Lawsuit with the Schall Law FirmApril 13 - Finnhub |
|
SANA INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Sana Biotechnology, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action LawsuitApril 13 - GlobeNewswire |
|
SANA Investors Have the Opportunity to Lead the Sana Biotechnology Securities Fraud Lawsuit with Faruqi & Faruqi, LLPApril 13 - GlobeNewswire |
|
 |
Sana Biotechnology, Inc. (NASDAQ:SANA) Stake Raised by ExodusPoint Capital Management LPApril 13 - ETF Daily News |
|
Sana Biotechnology, Inc. (NASDAQ:SANA) Receives $10.80 Consensus Price Target from BrokeragesApril 12 - ETF Daily News |
Financial performance View All
| Revenue | Cost of Revenue | Gross Profit | Net Income | ebitda | EPS | |
|---|---|---|---|---|---|---|
| Q3 '24 | 0 | 14M | -14M | -60M | -57M | -0.250 |
| Q2 '24 | 0 | 16M | -16M | -50M | -46M | -0.320 |
| Q1 '24 | 0 | 16M | -16M | -107M | -104M | -0.320 |
| Q4 '23 | 0 | 21M | -21M | -88M | -81M | -0.410 |
| Q3 '23 | 0 | 19M | -19M | 980,000 | 2.3M | 0.020 |
Insider Transactions View All
| FMR LLC filed to sell 4,541,511 shares at $7.3. January 10 '25 |
| FMR LLC filed to sell 4,707,423 shares at $6.5. January 10 '25 |
| FMR LLC filed to sell 4,732,423 shares at $6.1. January 10 '25 |
| FMR LLC filed to sell 4,542,511 shares at $6.7. January 10 '25 |
| Mulligan Richard filed to sell 2,698,121 shares at $3.9. September 26 '24 |
Similar companies
Read more about Sana Biotechnology (SANA) and their ai stock analysis, price prediction, earnings, congress trading, insider transactions, technical analysis, job posts, sentiment, webpage traffic, employee rating, google trends, 4chan mentions, reddit mentions, stocktwits mentions, stocktwits subscribers, twitter mentions, news mentions, customer reviews, business outlook & linkedin employees.
What is the Market Cap of Sana Biotechnology?
The Market Cap of Sana Biotechnology is $396M.
What is the current stock price of Sana Biotechnology?
Currently, the price of one share of Sana Biotechnology stock is $1.81.
How can I analyze the SANA stock price chart for investment decisions?
The SANA stock price chart above provides a comprehensive visual representation of Sana Biotechnology's stock performance over time. Investors can use this chart to identify patterns, trends, and potential support or resistance levels. By examining historical data and recent price movements, investors can make more informed decisions regarding buying, holding, or selling Sana Biotechnology shares. Our platform offers an up-to-date SANA stock price chart, along with technical data analysis and alternative data insights.
Does SANA offer dividends to its shareholders?
As of our latest update, Sana Biotechnology (SANA) does not offer dividends to its shareholders. Investors interested in Sana Biotechnology should consider the potential for capital appreciation as the primary return on investment, rather than expecting dividend payouts.
What are some of the similar stocks of Sana Biotechnology?
Some of the similar stocks of Sana Biotechnology are Amgen, Gilead Sciences, Catalyst Pharmaceuticals, Inovio Pharmaceuticals, and Anavex Life Sciences.
.